Stifel Nicolaus Cuts ALX Oncology (NASDAQ:ALXO) Price Target to $1.50
ALX Oncology (NASDAQ:ALXO – Free Report) had its target price reduced by Stifel Nicolaus from $3.00 to $1.50 in a research report sent to investors on Friday morning,Benzinga reports. They currently have a hold rating on the stock. ALXO has been the subject of a number of other reports. Cantor Fitzgerald reissued an “overweight” rating […]
ALX Oncology (NASDAQ:ALXO – Free Report) had its target price reduced by Stifel Nicolaus from $3.00 to $1.50 in a research report sent to investors on Friday morning,Benzinga reports. They currently have a hold rating on the stock. ALXO has been the subject of a number of other reports. Cantor Fitzgerald reissued an “overweight” rating […]
